Human Investing LLC Dexcom Inc Transaction History

Human Investing LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 02, 2021	SELL	$80.99 - $107.93 $3,887 - $5,180	-48 Closed	0 $0
Q2 2020 Jul 22, 2020	SELL	$62.68 - $105.34 $18,490 - $31,075	-295 Reduced 86.01%	48 $19,000
Q1 2020 Apr 22, 2020	BUY	$47.79 - $75.63 $14,098 - $22,310	295 Added 614.58%	343 $92,000
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $1,295 - $1,793	48 New	48 $6,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Human Investing LLC, based on Form 13F filings with the SEC.

Stay updated on Human Investing LLC with notifications on news.